In the United States, kidney transplant rates vary significantly across end-stage renal disease (ESRD) networks. We conducted a population-based cohort study to determine whether there was variability in kidney transplant rates across renal programs in a health care system distinct from the United States. We included incident chronic dialysis patients in Ontario, Canada, from 2003 to 2013 and determined the 1-, 5-, and 10-year cumulative incidence of kidney transplantation in 27 regional renal programs (similar to U.S. ESRD networks). We also assessed the cumulative incidence of kidney transplant for "healthy" dialysis patients (aged 18-50 years without diabetes, coronary disease, or malignancy). We calculated standardized transplant ratios (STRs) using a Cox proportional hazards model, adjusting for patient characteristics (maximum possible follow-up of 11 years). Among 23 022 chronic dialysis patients, the 10-year cumulative incidence of kidney transplantation ranged from 7.4% (95% confidence interval [CI] 4.8-10.7%) to 31.4% (95% CI 16.5-47.5%) across renal programs. Similar variability was observed in our healthy cohort. STRs ranged from 0.3 (95% CI 0.2-0.5) to 1.5 (95% CI 1.4-1.7) across renal programs. There was significant variation in kidney transplant rates across Ontario renal programs despite patients having access to the same publicly funded health care system.
Introduction
Compared with dialysis, kidney transplantation is associated with improved survival and quality of life and lower health system costs (1) (2) (3) (4) . The demand for deceased donor kidney transplantation continues to outpace supply, resulting in long waiting times and some patients dying on the waitlist or becoming too sick to be transplanted (5) . Although living kidney donor transplantation can help alleviate these long waiting times, multiple barriers to living donor transplantation exist (6) . Determining factors that influence access to kidney transplantation will inform future interventions to improve kidney transplantation rates. Previous non-Canadian studies have found an association between programs in which a patient receives dialysis and access to kidney transplantation (7) (8) (9) . In the United States, for example, transplantation rates have been found to vary more than twofold across end-stage renal disease (ESRD) networks, in which lower rates are observed in for-profit compared with not-for-profit programs (7) . In a universal health care setting, access to kidney transplantation would be expected to be more equitable because factors such as for-profit status would not play a role. Nevertheless, a study conducted in the United Kingdom, where residents have universal health care, found significant variation across dialysis programs in the percentage of dialysis patients who received a kidney transplant, with estimates varying from 8% to 47% (8) . Potential explanations for this variation include differences across programs in transplant referral rates, amount and quality of transplant education provided to potential recipients, the dialysis program's staff:patient ratio, and the availability of kidneys for transplant (7) .
To our knowledge, no previous Canadian studies have examined whether variability in kidney transplant rates exists across renal programs. One previous Canadian study found kidney transplant rates varied significantly across provinces, with the likelihood of transplantation more than threefold higher in Alberta compared with Ontario (10); however, they did not examine transplant rates within individual provinces or variability in rates across renal programs and included kidney transplants only from deceased donors. It is important to understand if such variability exists across renal programs within provinces because Canada has a unique health care system in which all residents receive universal access to health care and each province controls its delivery of health care; therefore, many health care solutions are delivered at the provincial level. If differences in access to kidney transplantation were found, it could provide an opportunity for provincewide interventions to ensure equitable access to transplantation. Consequently, we conducted this study to determine whether variation in kidney transplantation exists across 27 regional renal programs in Ontario, Canada. We also examined whether potential variations in transplant rates across programs could be explained by patient-and program-level differences in renal programs.
Methods

Design and setting
We conducted a retrospective population-based cohort study using health care databases held at the Institute for Clinical Evaluative Sciences (ICES) in Ontario, Canada, where residents have universal health care access. These data sets were deterministically linked using unique encoded identifiers and were analyzed at ICES. This study was approved by the institutional review board at Sunnybrook Health Sciences Centre, Toronto, Canada. We followed guidelines for observational studies in the reporting of this study (11, 12) .
Data sources
We obtained information from six linked databases. We used the Ontario Renal Reporting System (ORRS; January 1, 2010, to December 31, 2013) and the Canadian Organ Replacement Register (CORR; January 1981 to December 2013) to obtain information on chronic dialysis patients and kidney transplantation; in 2013, CORR reported that its incident dialysis records were 99% complete in Ontario (13) . We obtained information on vital status and demographics from the Ontario Registered Persons Database. For information on physician health services claims, we used the Ontario Health Insurance Plan database. We used the Canadian Institute for Health Information Discharge Abstract Database for diagnostic information for hospital admissions, and information on emergency department visits was provided by the National Ambulatory Care Reporting System.
Cohort
We included all incident chronic dialysis patients in Ontario from January 1, 2003, to December 31, 2013 . We excluded patients with the following characteristics: not Ontario resident; aged <18 or ≥105 years at dialysis initiation; previous history of chronic dialysis or transplantation (including kidney); and receipt of a preemptive kidney transplant (i.e. patients who never received dialysis; <15% of all kidney transplants during the period of study). We also excluded patients from the St. Boniface General Hospital in Winnipeg, Canada, because of the small number of patients who received dialysis at this program; patients from northern Ontario may receive dialysis at this facility given its proximity. We defined the index date (cohort entry date) as the date of chronic dialysis initiation.
Outcome
Our primary outcome was receipt of a kidney transplant at 1, 5, and 10 years after dialysis initiation, as captured in CORR or ORRS (Table S1) . CORR has been shown to accurately identify kidney transplant recipients compared with data from transplant centers, with sensitivity >95% (14) .
Renal programs
In Ontario (population 13.6 million), the Ontario Renal Network, a provincial government agency, is responsible for connecting and coordinating the province's regional renal programs, which oversee 97 dialysis centers comprising >11 000 chronic dialysis patients (15) . These regional renal programs are comparable to the ESRD networks in the United States. Six Ontario adult transplant centers receive referrals from the regional renal programs. In 2013, the median number of chronic dialysis patients per renal program was 79 (interquartile range [IQR] 45-116). We stratified our results by 27 regional renal programs in Ontario. In 2014, Toronto East General Hospital merged with the St. Michael's Hospital renal program, resulting in 26 renal programs. Our study follow-up ended in 2013; therefore, we included Toronto East General Hospital as a separate program. To ensure anonymity, we assigned a unique random number to each program. Because patients may switch renal programs during follow-up, we examined the renal program in which patients initiated dialysis compared with their renal programs at 90 days, 1 year, and 3 years. Program transfers were not a concern in this cohort, with <10% of participants changing programs at all of these follow-up times; therefore, for the purposes of this analysis, patients were assigned to the renal program in which they initiated chronic dialysis.
Statistical analysis
Baseline characteristics are presented as median (IQR) for continuous variables and as proportion for categorical variables. We calculated the unadjusted 1-, 5-, and 10-year cumulative incidence of kidney transplantation with corresponding confidence intervals (CIs) using the cumulative incidence function (CIF), which accounts for the competing risk of death (16) . The CIF keeps patients who died in the risk set by using inverse probability weighting; as such, participants who died contributed less to the risk set than those who did not die and were still at risk of the event. CIF is suggested for use when the risk of death is high to avoid potentially overestimating the incidence of transplant (16, 17) .
To account for differences in patient characteristics across programs, we used the same cohort of incident chronic dialysis patients to calculate adjusted standardized transplant ratios (STRs) with corresponding CIs for each renal program, censoring at death, date of last contact in administrative data sources, or end of follow-up (December 31, 2013; maximum possible follow-up was 11 years). STRs were standardized to the Ontario population and calculated by comparing the ratio of the observed number of kidney transplants with the number of transplants we would expect for the average Ontario dialysis patient. The expected number of transplants in each program was calculated using a Cox proportional hazards model (18) . An STR of 1 indicated that the renal program's observed kidney transplant rate was equal to the expected rate based on data from all dialysis patients in Ontario. STR >1.0 indicated that the observed transplant rate was higher than expected, whereas STR <1.0 indicated that the observed transplant rate was lower than expected. We adjusted for the following patient-level variables: age, sex, race, year of chronic dialysis initiation, diabetes, BMI, neighborhood income quintile, rurality (rural defined as population <10 000), cause of ESRD, dialysis modality at initiation (i.e. peritoneal or hemodialysis), and adjusted clinical groups (ACG) score. ACG is a population/case mix-adjusted comorbidity measure of expected health care resource consumption that is calculated by categorizing International Classification of Diseases codes into 32 ambulatory diagnostic groups based on chronicity, disability, clinical similarity, and need for specialty care (19) . In an additional analysis, we calculated STRs restricted to patients aged <70 years at dialysis initiation and adjusted for age and year of chronic dialysis initiation; this is consistent with the Centers for Medicare and Medicaid Services calculation of STR (20) . Using this STR calculation, we categorized renal programs into tertiles and compared characteristics across programs using the Kruskal-Wallis test for continuous variables and the chi-square test for categorical variables. Detailed information on the STR methodology can be found in the Supporting Information.
We conducted all aforementioned analyses in a subpopulation of patients with better health status at dialysis initiation. "Healthy" was defined as someone who should be eligible for transplantation without overt contraindication (aged 18-50 years without diabetes, coronary disease, or malignancy). "Less healthy" was defined as anyone not included in the healthy category. In an additional analysis, we looked at transplant incidence for deceased and living donor kidney transplantation, examined separately. When assessing those who received organs from deceased donors, death and receipt of a living donor transplant were both treated as competing risks in the cumulative incidence calculation and as censoring events in the STR analysis.
Data were missing for the following variables (0.03-10% depending on the variable): BMI (imputed age-and sex-weighted median), race (imputed white), income quintile (imputed quintile 3), rurality (imputed urban), dialysis modality (imputed hemodialysis), and cause of ESRD (imputed other). To determine the effect of missing data on our results, we performed a sensitivity analysis restricted to complete cases. Emigration from the province was the only reason for loss to follow-up (<0.5% annually) (21) . We used SAS Enterprise Guide version 9.4 (SAS Institute, Cary, NC) to perform all analyses. A two-sided p < 0.05 was considered statistically significant.
Results
Baseline characteristics
We included 23 022 incident chronic dialysis patients ( Figure S1 Table 1 describes baseline characteristics for the entire cohort and the healthy subcohort of chronic dialysis patients (n = 1856). The median age in the entire cohort was 67 years (IQR 56-77 years), 39.9% were women, and 58.7% had diabetes. In the healthy cohort, the median age was 40 years (IQR 31-46 years), and 41.4% were women. Incidence of kidney transplantation by renal program The cumulative incidence of kidney transplantation varied significantly across renal programs (Figure 1 ), and this variation persisted in analyses restricted to the healthy subcohort of dialysis patients and examining living and deceased donor transplantation separately (Table S2 ). The 10-year cumulative incidence of kidney transplantation, for example, ranged from 7.4% (95% CI 4.8-10.7%) to 31.4% (95% CI 16.5-47.5%), with median cumulative incidence of 17.2%. When we restricted our cohort to healthy chronic dialysis patients (n = 1809), the 10-year cumulative incidence ranged from 32.5% (95% CI 13.5-53.2%) to 82.7% (95% CI 68.1-91.1%), with a median of 65.8%.
When examining kidney transplantation from deceased and living donors separately, the 10-year cumulative incidence of transplant also varied significantly across renal programs. The 10-year cumulative incidence for deceased donor kidney transplantation ranged from 1.9% (95% CI 1.0-3.2%) to 12.6% (95% CI 11.1-14.2%), with a median of 7.1%; for living donor kidney transplantation, 10-year cumulative incidence ranged from 0.9% (95% CI 0.4-2.1%) to 7.6% (95% CI 4.1-12.7%), with a median of 4.0%. When restricted to the healthy subcohort, the 10-year cumulative incidence for deceased donor transplantation ranged from 5.3% (95% CI 0.2-23.8%) to 39.9% (95% CI 31.6-48.0%), with a median of 21.1% (Figure 2) . Similarly, the 10-year cumulative incidence for living donor kidney transplantation ranged from 4.3% (95% CI 0.8-13.2%) to 33.3% (95% CI 18.5-48.9%), with a median of 21.2% (Figure 3) .
Standardized transplant ratios
The adjusted STRs varied significantly across renal programs, ranging from 0.3 (95% CI 0.2-0.5) to 1.5 (95% CI 1.4-1.7) ( Figure 4A ). When restricting our analysis to the healthy subcohort of dialysis patients, significant variation persisted across programs, with STRs ranging from 0.4 (95% CI 0.2-0.8) to 2.2 (95% CI 1.04-4.6) ( Figure 4B ). Similar results were found when examining kidney transplantation for deceased and living donor kidney transplantation separately ( Figures S2 and S3 ).
The STRs varied significantly across renal programs in analyses restricted to dialysis patients aged <70 years and adjusted for age and year of chronic dialysis initiation (n = 12 861), with STRs ranging from 0.3 (95% CI 0.2-0.4) to 1.7 (95% CI 1.1-2.4) ( Figure S4 ). 
Sensitivity analysis
When performing the complete case analysis (n = 19 338), results were similar, with significant variation in kidney transplantation across renal programs. Specifically, the 10-year cumulative incidence of kidney transplantation ranged from 7.9% (95% CI 5.0-11.6%) to 27.5% (95% CI 21.8-33.5%), and the STRs ranged from 0.3 (95% CI 0.2-0.5) to 1.5 (95% CI 1.3-1.7).
Discussion
In this study, we found significant variation in the incidence of kidney transplantation across renal programs. Differences persisted when restricting our cohort to a healthier subpopulation of dialysis patients, when assessing by donor type, and when adjusting for patient-level factors. Our results suggest that, despite universal access to health care, disparities in access to kidney transplantation exist in Ontario.
Consistent with previous studies conducted in both universal and private health care settings, we found significant variation in kidney transplantation across renal programs (7-9). There are several potential explanations for this variation. First, there may be differences in the likelihood of the renal program to refer a patient for a kidney transplant evaluation. Patzer et al found significant differences in the proportion of dialysis patients referred for kidney transplant evaluation across U.S. dialysis facilities (22) . Second, renal programs often send their patients to a specific transplant center based on proximity; therefore, transplant center-level factors such as differences in organ access and acceptance may affect transplant rates. During the study period and prior to the introduction of a provincial organ allocation system, deceased donor organs were allocated exclusively to the nearest transplant program (23) . Regional variation in deceased organ donation rates may have affected local wait times and explained some between-program variability in transplantation rates. Third, there may be differences across renal programs in the staff:patient ratio. Patzer et al found that programs from the United States with less staff had a lower STR (7).
A fourth reason for the observed variation in kidney transplantation may relate to differences across renal programs in the number of patients who are late chronic kidney disease referrals (referred to nephrologists <90 days prior to initiating dialysis). Previous studies have found that patients who are referred late for chronic kidney disease care are less likely to receive a transplant (24, 25) . Fifth, there may be differences in the amount of transplant education provided at each program. Waterman et al found renal programs that provide more than three educational strategies have more patients on the transplant waitlist (26) . In Ontario, it is suggested that renal programs inform patients about whether or not they have a permanent contraindication to proceed with an evaluation for kidney transplantation by a transplant center; however, this is not mandated. Sixth, the distance of the renal program to the transplant center may affect the rate of transplantation; however, previous Canadian studies have found no association between patient distance from the transplant center and access to transplant (10, 27) . Moreover, we found that rural residence was actually associated with a higher transplant rate. Last, unmeasured facility-and patient-level factors may account for some variability; for example, we were not able to measure factors such as smoking status and religious or cultural beliefs, both of which have been previously found to affect transplant rates (28, 29) .
When assessing patient-and renal program-level factors associated with STRs, we found many significant differences across STR tertiles, although the absolute difference across tertiles for many of these factors was quite small. Nonwhite race, for example, was associated with a lower STR. These results are consistent with a previously conducted study in the United States (7). We found that renal programs with a higher proportion of white patients had higher STRs, suggesting a need for culturally sensitive interventions to improve access to kidney transplantation.
Interestingly, we found that renal programs with high rates of deceased donor kidney transplantation often had lower rates of living donor transplantation. This result has been found previously, with countries with high deceased donation rates often having low living kidney donor rates (30) ; however, to our knowledge, this has not been found across renal programs. A potential explanation for this finding is that shorter waiting times for deceased donation at programs may decrease the need for patients to seek out living donors (31) . Given that recipients who receive a kidney from a living donor have superior patient and transplant survival, this area requires further research (32) (33) (34) . Perhaps such programs need targeted investment in more living donor coordinators or educators to facilitate living kidney transplantation.
These results have important implications for policy makers. Based on the STRs for the entire dialysis cohort, we can classify renal programs into three groups: higher performing Ontario renal programs (STR significantly >1), average performing (STR not significantly different from 1), and lower performing (STR significantly <1). In our study, there were six renal programs that would be considered higher performing within the province of Ontario, 15 that were average performing, and six that were lower performing. Implementation of best practices from high-performing programs may lead to improvements in transplantation at the lower performing programs.
This study has several strengths. Universal health care benefits allowed us to include all Ontario dialysis patients, minimizing concerns about selection bias. This is the first Canadian study to identify variability in kidney transplant rates between renal programs-despite universal health care access-for which some of the variability could be due to modifiable practices, highlighting an area for targeted interventions. We also were able to demonstrate variation across programs independent of patientlevel characteristics. Last, to avoid overestimating the cumulative incidence of kidney transplantation, we accounted for the competing risk of death (17) .
The limitations of this study should be noted. First, we did not have data regarding which patients were on the kidney transplant waiting list; however, we attempted to emulate the waiting list in additional analyses by restricting our cohort to healthier dialysis patients who would most likely be eligible for transplant, and we still found significant variation in kidney transplant rates across programs. Second, because of the limitations of administrative databases, we were not able to adjust for all possible confounders (e.g. religion, smoking). Third, most renal programs use a shared model of care, with more than one physician caring for the same dialysis patient. It is not clear if the differences we found were due to the practices of certain physicians, case-managers, other staff, or facility-level factors. In an additional analysis, we found several factors that may be associated with transplant rates; however, future studies should further examine potentially modifiable factors that may explain this variation (e.g. staff:patient ratio, number of social workers). Fourth, because of the relatively small number of transplants, we were not able to restrict our cohort to participants who more recently started dialysis (e.g. initiated dialysis between 2010 and 2013). Fifth, our analysis was limited to Ontario dialysis patients; given the provincial delivery of health care in Canada, our results may not be generalizable to other provinces. Sixth, the STRs calculated in this study were standardized to the Ontario dialysis population and thus do not provide information on how Ontario is doing compared with other provinces in Canada and other countries. Nevertheless, based on national data, we know that Ontario is performing slightly below the national average, with 39.5% of Ontario ESRD patients receiving a kidney transplant compared with the national average of 42.5% (35) . Last, we did not include preemptive transplants. Given that these transplants represent <15% of total transplants, we do not expect that this group would significantly change results. Moreover, the exclusion of preemptive transplants is consistent with the U.S. calculation of STRs (20) .
We observed substantial variability in kidney transplant rates across renal programs in Ontario despite patients having access to the same publicly funded universal health care system. Future studies should examine whether variation exists at other steps in the kidney transplant process (e.g. referral, evaluation, waitlisting). Further research is also needed to better understand why variation in transplant rates exists to facilitate the development of targeted interventions (e.g. educational initiatives) to improve access to kidney transplantation for ESRD patients. Ongoing measurement and reporting of the transplant rate by renal program may be a useful quality metric to drive system improvement.
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